Veeva Systems, the software company that dominates the life-sciences industry, is in the middle of a major product transition. The company is pushing its largest pharmaceutical clients onto its newer Vault CRM platform, and according to Truist Securities, that effort is turning into a longer growth runway than many investors had anticipated.
In a note to clients, Truist said the next six to eight months of top-customer migrations, combined with steady adoption of artificial intelligence tools, could keep demand for Veeva's paid implementation services elevated before it eventually normalizes. The bank's analysts see the upgrade cycle as a multi-quarter opportunity rather than a quick, one-off boost.
What's driving the extended runway?
Veeva's Vault CRM is the company's next-generation customer relationship management system, built specifically for the pharmaceutical and biotech industries. It replaces the older Salesforce-based CRM that many drugmakers have used for years. The transition is significant because it involves moving complex, highly regulated sales operations onto a new platform, which requires substantial professional services work.
According to Truist, five of Veeva's top 20 customers are already live on Vault CRM, but seven have not yet reached full production use. That gap suggests a meaningful portion of the migration work is still ahead. Truist expects migrations among these top accounts to "meaningfully expand" over the next six to eight months, which should keep services revenue flowing.
Veeva itself has guided that overall migration activity will stay near its current pace for the next 18 months. That longer-than-typical timeline is a key reason Truist sees the services demand as more durable than some investors might have assumed.
AI adoption adds to the services tailwind
Beyond the core migration work, Truist also points to steady adoption of Veeva's AI-powered features as a secondary driver of services demand. As life-sciences companies look to use AI for everything from sales forecasting to regulatory compliance, they often need help integrating those tools into their existing workflows. That creates additional consulting and implementation work for Veeva's professional services team.
The AI angle is not unique to Veeva. Across the software industry, companies are seeing a similar pattern: customers are buying AI features, but they also need help deploying them. For Veeva, the combination of a major platform migration and AI adoption means its services business could stay busy for longer than the typical upgrade cycle.
What it means for investors
For everyday investors, the key takeaway is that Veeva's growth story is not just about selling software licenses. A significant portion of the company's revenue comes from professional services—the implementation, training, and consulting work that helps customers get the most out of the platform. When that work is tied to a multi-year migration cycle, it can provide a more predictable revenue stream.
Truist's view suggests that Veeva's services revenue could remain elevated for at least the next two quarters, and possibly longer. That could support the company's overall growth rate and give investors more confidence in its near-term financial performance.
However, it's also worth noting that this kind of services-driven growth is not permanent. Once the top customers have migrated and AI tools are fully integrated, the demand for implementation work will naturally taper off. Truist explicitly says the elevated demand will eventually normalize, which is a reminder that Veeva's growth will likely slow once the current cycle runs its course.
For investors, the question is whether the stock already reflects that eventual slowdown. Veeva has long been a high-multiple stock, meaning investors are paying a premium for its growth. If the services tailwind extends longer than expected, that premium may be justified. But if the migration cycle ends sooner than anticipated, the stock could face pressure.
In the broader context, Veeva's situation is similar to other software companies that are undergoing major platform transitions. The key is to watch how quickly the top customers complete their migrations and how much AI-related work follows. Truist's analysis suggests the next six to eight months will be a critical period.
For now, the message from Truist is clear: Veeva's Vault CRM push is not a sprint—it's a marathon. And that could be good news for investors who are patient.
